{"id":35464,"date":"2025-06-17T15:04:02","date_gmt":"2025-06-17T19:04:02","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_news&#038;p=35464"},"modified":"2025-07-09T13:07:05","modified_gmt":"2025-07-09T17:07:05","slug":"cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","title":{"rendered":"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy"},"content":{"rendered":"\n<p>New York, NY \u2014&nbsp;In a new collaboration that could transform how cancer is treated, the Cancer Research Institute (CRI) is partnering with the OCCAM Immune\u2014a Mount Sinai initiative focused on understanding the immune system\u2019s role in disease\u2014to unlock the secrets of how the immune system responds to advanced therapies.<\/p>\n\n\n\n<p>Under the agreement, CRI and OCCAM Immune have established a long-term plan to support ongoing immune monitoring across CRI\u2019s clinical trials. The collaboration provides a flexible framework for launching new projects efficiently and will focus on tracking how patients\u2019 immune systems respond to treatment, with the goal of identifying which patients are most likely to benefit from certain immunotherapies and why.<\/p>\n\n\n\n<p>The collaboration was sparked by <a href=\"https:\/\/profiles.mountsinai.org\/thomas-u-marron\" target=\"_blank\" rel=\"noreferrer noopener\">Thomas Marron, MD, PhD<\/a>, Director of the Early Phase Trial Unit at <a href=\"https:\/\/icahn.mssm.edu\/research\/tisch\" target=\"_blank\" rel=\"noreferrer noopener\">The Tisch Cancer Institute<\/a> at Mount Sinai and Chief Medical Officer of OCCAM Immune. Recognizing a shared vision between the two organizations, Dr. Marron brought Mount Sinai and CRI together to accelerate progress in immunotherapy, a treatment that helps the body\u2019s own immune system fight cancer.<\/p>\n\n\n\n<p>\u201cWe\u2019re thrilled to team up with the Cancer Research Institute on this important work. CRI brings decades of experience in cancer immunotherapy and access to rich clinical trial samples from around the world,\u201d says Dr. Marron. \u201cAt OCCAM Immune, we\u2019re bringing powerful tools to analyze the immune system and the expertise to turn complex data into insights that matter to doctors, scientists, and, ultimately, patients. By working together, we aim to better understand how different therapies interact with the immune system and use that knowledge to make cancer care more personalized and effective.\u201d<\/p>\n\n\n\n<p>Immunotherapy has transformed cancer treatment, but it doesn\u2019t work for everyone. OCCAM Immune is helping uncover why by mapping how the immune system responds to therapy\u2014insights that can improve care not just for cancer, but for autoimmune and inflammatory diseases as well. By combining clinical expertise with advanced lab tools, OCCAM Immune supports researchers and companies worldwide in developing more precise, effective therapies.<\/p>\n\n\n\n<p>OCCAM Immune operates in collaboration with Mount Sinai\u2019s robust medical and research ecosystem, led by pioneers including\u202f <a href=\"https:\/\/www.meradlab.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Miriam Merad, MD, PhD<\/a>, whose work has shaped our understanding of how the immune system controls cancer. Dr. Merad is Dean for Translational Research and Therapeutic Innovation, Director of the\u202f<a href=\"https:\/\/icahn.mssm.edu\/research\/immunology\" target=\"_blank\" rel=\"noreferrer noopener\">Marc and Jennifer Lipschultz Precision Immunology Institute<\/a> (PrIISM),\u202fand Chair of Immunology and Immunotherapy at the Icahn School of Medicine at Mount Sinai.\u202fThrough PrIISM, OCCAM Immune offers partners access to rare clinical samples, cutting-edge analysis, and a proven track record of discovery.<\/p>\n\n\n\n<p>\u201cWe are proud to partner with OCCAM Immune and Mount Sinai on this important effort to advance our understanding of how the immune system responds to cancer therapies,\u201d says Alicia Zhou, PhD, CRI\u2019s Chief Executive Officer. \u201cOCCAM Immune\u2019s expertise in immune profiling and data interpretation, paired with CRI\u2019s network of immunotherapy trials, creates a powerful synergy. Together, we\u2019re not only accelerating the pace of discovery but also moving closer to a future where every patient receives the treatment most likely to be effective for them.\u201d<\/p>\n\n\n\n<p>The collaborative work is set to begin with a clinical trial in women with ovarian cancer, where researchers will closely study immune cells and tumors from patients treated with novel drug combinations. The focus will be on platinum-resistant high-grade serous ovarian cancer, an aggressive type of ovarian cancer that often returns after treatment. OCCAM Immune scientists will analyze 160 blood samples and tumor biopsies using cutting-edge technologies like RNA\/DNA sequencing and immune cell mapping. They aim to understand how the body responds to these treatments and identify markers that could help match future patients with the most effective therapies.<\/p>\n\n\n\n<p>\u201cThis collaboration with the Cancer Research Institute marks an important step forward\u2014not just for OCCAM Immune, but for the field of immunotherapy as a whole,\u201d says Dr. Merad. \u201cIt reflects growing recognition of our ability to generate and interpret high-quality immune data, which is essential as personalized medicine and AI-driven drug development continue to advance. We\u2019re delighted to partner with CRI and other leaders across academia, biotech, and pharma to accelerate discoveries that help unlock the full potential of the immune system and improve outcomes for patients.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New York, NY \u2014&nbsp;In a new collaboration that could transform how cancer is treated, the Cancer Research Institute (CRI) is partnering with the OCCAM Immune\u2014a Mount Sinai initiative focused on understanding the [&hellip;]<\/p>\n","protected":false},"featured_media":35465,"template":"","tags":[],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-35464","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"New York, NY \u2014&nbsp;In a new collaboration that could transform how cancer is treated, the Cancer Research Institute (CRI) is partnering with the OCCAM Immune\u2014a Mount Sinai initiative focused on understanding the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-09T17:07:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy\",\"name\":\"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp\",\"datePublished\":\"2025-06-17T19:04:02+00:00\",\"dateModified\":\"2025-07-09T17:07:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp\",\"width\":770,\"height\":420,\"caption\":\"Closeup of a Microscope\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","og_locale":"es_ES","og_type":"article","og_title":"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute","og_description":"New York, NY \u2014&nbsp;In a new collaboration that could transform how cancer is treated, the Cancer Research Institute (CRI) is partnering with the OCCAM Immune\u2014a Mount Sinai initiative focused on understanding the [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","og_site_name":"Cancer Research Institute","article_modified_time":"2025-07-09T17:07:05+00:00","og_image":[{"width":770,"height":420,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","url":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy","name":"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp","datePublished":"2025-06-17T19:04:02+00:00","dateModified":"2025-07-09T17:07:05+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/06\/Mount_Sinai_and_Cancer_Research_Institute_Team_Up_to_Improve_Patient_Outcomes_in_Immunotherapy.webp","width":770,"height":420,"caption":"Closeup of a Microscope"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/cancer-research-institute-and-mount-sinai-team-up-to-improve-patient-outcomes-in-immunotherapy#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/35464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/35465"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=35464"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=35464"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=35464"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=35464"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=35464"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=35464"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=35464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}